| dc.date.accessioned | 2014-08-28T10:48:57Z | |
| dc.date.available | 2014-08-28T10:48:57Z | |
| dc.date.issued | 2014 | |
| dc.identifier.uri | http://hdl.handle.net/10852/40302 | |
| dc.language.iso | en | en_US |
| dc.relation.haspart | Paper I: Nucleolin regulates phosphorylation and nuclear export of fibroblast growth factor 1 (FGF1). Torunn Sletten, Michal Kostas, Joanna Bober, Vigdis Sorensen, Mandana Yadollahi, Sjur Olsnes, Justyna Tomala, Jacek Otlewski, Malgorzata Zakrzewska, Antoni Wiedlocha. Accepted version. Published in: PLoS ONE 9(3): e90687. This is an open-access article distributed under the terms of the Creative Commons Attribution License. The published version is available at: https://doi.org/10.1371/journal.pone.0090687 | |
| dc.relation.haspart | Paper II: Different anti-leukemic activity of the HSP90 inhibitor NVP-AUY922 during in vitro and in vivo treatment of human leukemic KG-1a cells. Torunn Sletten, Skjalg Bruheim, Antoni Wiedlocha. Not yet published. The paper is not available in DUO due to publisher restrictions. | |
| dc.relation.haspart | Paper III: The ER-protein LRRC59 is involved in regulating epithelial cell polarization, directed migration, and lumen expansion in Caco-2 cysts Torunn Sletten, Antoni Wiedlocha, Vigdis Sorensen. Not yet published. The paper is not available in DUO due to publisher restrictions. | |
| dc.relation.uri | https://doi.org/10.1371/journal.pone.0090687 | |
| dc.title | Role of intracellular FGFI interaction partners, and HSP90 as a therapeutic target in FGFRI driven malignancy | en_US |
| dc.type | Doctoral thesis | en_US |
| dc.creator.author | Sletten, Torunn | |
| dc.identifier.urn | URN:NBN:no-45036 | |
| dc.type.document | Doktoravhandling | en_US |
| dc.identifier.fulltext | Fulltext https://www.duo.uio.no/bitstream/handle/10852/40302/1/PhD-Sletten-DUO.pdf | |